ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3246

Does Loss of a Community Walking Speed Lead to More Symptoms of Depression in Knee OA? a Trajectory Analysis from the Osteoarthritis Initiative

Daniel White1, Tuhina Neogi2, Yuqing Zhang3, Jingbo Niu4 and Patricia P. Katz5, 1Department of Physical Therapy, University of Delaware, Newark, DE, 2Clinical Epidemiology, BUSM, Boston, MA, 3BUSM, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Rheumatology, UCSF, SF, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: depression, osteoarthritis and physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 11, 2015

Title: ARHP V: Physical Activity

Session Type: ARHP Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Knee osteoarthritis (OA) is a
well-known risk factor for major depression.  While major limitations, e.g., inability
to walk, are thought to mediate this relationship, it is not known to what
extent minor limitations, i.e., not walking at a community speed, may contribute
to depressive symptoms.  The purpose
of this study was to investigate the association of minor and major limitations
in walking speed with trajectories of depressive symptoms among people with or
at high risk of knee OA.   

Methods: We utilized data from the
Osteoarthritis Initiative (OAI) to describe trajectories of depressive symptoms
over 84-months.  Depressive symptoms
were measured annually with the Center for Epidemiologic Studies Depression
Scale (CES-D) which ranges from 0 to 60, with higher
scores representing more depressive symptoms.  We included only participants with CES-D
< 16, which represents those without major depression.  Gait speed was measured from the
20-meter walk test at baseline.  We
categorized ‘No limitation’ as ≥ 1.2 meters/second (m/s) which
represents the minimum time needed to walk across a timed crosswalk, i.e., a community
walking speed; ‘Minor limitation’ as < 1.2 m/s and ≥ 1.0 m/s; and
‘Major limitation’ as < 1.0 m/s which is associated with persistent
functional limitation, hospitalization, and death.  To describe trajectories of depressive
symptoms, we used a group-based method (PROC TRAJ) to agnostically identify
homogeneous clusters of developmental trajectories in OAI.  We then examined the relation of gait
speed categories with depressive symptom trajectories using multinomial
logistic regression adjusting for age, sex, BMI, race, education, radiographic
knee OA, and intensity of knee pain.

Results:   From the 3801 participants included (age
61.4 ± 9.1, BMI 28.4 ± 4.7, 57.5% women, 64% college degree), we identified
five depressive symptom trajectories. 
The first three trajectories were stable over time and had baseline
values < 6, on average, and included 74% of the sample.  The 4th and 5th
trajectories had worsening scores, increasing 0.4 and 1.0 points/year on the
CES-D and included 19% and 7% of the sample, respectively.  Study participants with minor limitation
had 1.7 and 1.9 times the adjusted risk of being in the 4th and 5th
trajectory groups, respectively.  Compared
with those without limitation, those with major limitation had 2.7 and 3.6
times the adjusted risk of being in the 4th and 5th
trajectory groups, respectively. (Table)

Conclusion:   Loss of the ability to walk a community speed appears to signal
risk for worsening worsening depressive symptoms over time in people with or at
high risk of knee OA.  Maintaining walking
speeds adequate to cross the street safely in the community may be important to
consider in order to maintain psychological well-being among people with knee
OA.   

Description: Macintosh HD:Users:Air2014:Desktop:Screen Shot 2015-06-11 at 11.21.10 AM.png


Disclosure: D. White, None; T. Neogi, None; Y. Zhang, None; J. Niu, None; P. P. Katz, None.

To cite this abstract in AMA style:

White D, Neogi T, Zhang Y, Niu J, Katz PP. Does Loss of a Community Walking Speed Lead to More Symptoms of Depression in Knee OA? a Trajectory Analysis from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/does-loss-of-a-community-walking-speed-lead-to-more-symptoms-of-depression-in-knee-oa-a-trajectory-analysis-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-loss-of-a-community-walking-speed-lead-to-more-symptoms-of-depression-in-knee-oa-a-trajectory-analysis-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology